Cancer: Wales among worst countries for survival, data suggests
Data suggests Wales ranks 32nd out of 33 similarly wealthy nations for surviving stomach cancer.
Data suggests Wales ranks 32nd out of 33 similarly wealthy nations for surviving stomach cancer.
Made with vegan and cruelty-free ingredients, this sunscreen is formulated with zinc oxide, squalane, chamomile and an antioxidant blend of vitamin E and ethyl ferulate. They work together to shield the skin from sun damage and to hydrate, soften and smooth the skin and protect against further damage from free radicals. The drops create an…
It’s the season when many people set New Year’s resolutions for the year ahead, and these goals are often related to physical health. Experts say there’s one big area that many people should focus on when it comes to their well-being: cardiovascular health. “Cardiovascular disease is the number one cause of death in America,” said…
BuzzFeed may collect a share of sales or other compensation from the links on this page if you decide to shop from them. All products were independently selected by our editors, and the prices were accurate and items in stock at the time of publication. Le Creuset is probably the most iconic brand in the…
In the 20th century, oil was the resource most likely to spark global conflict. In the 21st, that resource may well be water. As climate change reshapes rainfall, glaciers, and river flows, fresh water—once taken for granted—is becoming a source of growing geopolitical tension. Rivers that sustain millions of people are now at the center…
Jim Cramer ran through all 33 stocks in his Charitable Trust portfolio during the December edition of the CNBC Investing Club’s Monthly Meeting.
Soumyabrata Roy | Nurphoto | Getty Images Drugmakers are closing out a year when they achieved several historic firsts that will shape the pharmaceutical industry in 2024 and beyond. The weight loss drug market transformed into the pharmaceutical industry’s newest gold rush this year, as demand for costly but highly effective treatments from Novo Nordisk…